Back to search
FDAFDA · Food and drugs·Recall number D-0536-2026

Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-203-01; Individual Dose NDC: 68084-203-11

Published May 27, 2026 · Recall initiated: May 1, 2026

Summary

FDA records drug Class III recall D-0536-2026, published May 27, 2026 and initiated May 1, 2026. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 63,500 tablets; Lot: Lot#: 1027583, Exp 09/30/2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

What to do

Voluntary: Firm initiated · Letter

Get an email if PRIMIDONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PRIMIDONE
Manufacturer
Amerisource Health Services LLC
Distributor
USA Nationwide
Lot
Lot#: 1027583, Exp 09/30/2027
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-203-01; Individual Dose NDC: 68084-203-11 recalled?

Yes. FDA published recall D-0536-2026 on May 27, 2026. Reported hazard: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PRIMIDONE.